Skip to content

Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient Education

Establishing a Standard for Peri-operative ICD Patient Education: A Demonstration Project

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00845234
Enrollment
62
Registered
2009-02-18
Start date
2008-07-31
Completion date
2011-01-31
Last updated
2013-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia

Keywords

behavioral intervention, implantable cardioverter defibrillator, psychosocial education, anxiety, depression

Brief summary

An implantable cardioverter defibrillator (ICD) administers a shock to terminate potentially life-threatening cardiac arrhythmias. The device saves lives, but presents psychological challenges for patients. At present, there is a paucity of brief interventions for ICD patients designed for administration in a clinic setting that considers issues of cost, time, and available resources. The present study examined the impact of a brief cognitive behavioral (CBT) educational intervention on primary endpoints of patient acceptance and quality of life and secondary endpoints of depression and anxiety. It was hypothesized that the intervention would result in significant improvements primary and secondary endpoints for participants in the intervention group.

Interventions

BEHAVIORALIntervention

Intervention consisted of a brief, educational CBT intervention and included the following domain areas: ICD knowledge and post-discharge care, understanding shock, stress management, family and relationships, device recall, and survivorship. The intervention was provided at baseline (0 weeks). Intervention was led by investigator and lasted 15 minutes in duration.

Sponsors

Aurora Denver Cardiology Associates
CollaboratorUNKNOWN
Medtronic
CollaboratorINDUSTRY
East Carolina University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18+ years old * literate * newly implanted with an implantable cardioverter defibrillator (ICD)

Exclusion criteria

* documented neurological sequelae associated with CVA or dementia * documented cognitive impairment * reported illiteracy * previously implanted ICD

Design outcomes

Primary

MeasureTime frameDescription
Score on measure assessing construct of quality of lifeUp to 8 months after enrollmentQuality of life will be obtained via participants scores from the Medical Outcomes Survey Short Form-12 (SF-12) measure of quality of life.

Secondary

MeasureTime frameDescription
Score on measure assessing depressionUp to 8 months after enrollmentDepression will be assessed via participant's self-reported scores on the depression subscale of the Hospital Anxiety and Depression Scale (HADS).
score on measure assessing construct of patient acceptance of deviceup to 8 months after enrollmentThe Florida Patient Acceptance Scale measures patient's self-reported acceptance of the implantable cardioverter defibrillator.
score on measure assessing anxietyUp to 8 months after enrollmentThe Hospital Anxiety and Depression Scale is comprised of two subscales- anxiety and depression. It is a self-report measure that generates a score on the patient's current level of anxiety.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026